{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T02:20:09Z","timestamp":1767666009797},"reference-count":33,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2003,2,1]],"date-time":"2003-02-01T00:00:00Z","timestamp":1044057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2003,2]]},"DOI":"10.1016\/s0168-3659(02)00353-x","type":"journal-article","created":{"date-parts":[[2003,3,4]],"date-time":"2003-03-04T11:04:10Z","timestamp":1046775850000},"page":"107-115","source":"Crossref","is-referenced-by-count":44,"title":["Comparative study of GDNF delivery systems for the CNS: polymer rods, encapsulated cells, and lentiviral vectors"],"prefix":"10.1016","volume":"87","author":[{"given":"Jean-Charles","family":"Bensadoun","sequence":"first","affiliation":[]},{"given":"Luis","family":"Pereira de Almeida","sequence":"additional","affiliation":[]},{"given":"Eric G","family":"Fine","sequence":"additional","affiliation":[]},{"given":"Jack L","family":"Tseng","sequence":"additional","affiliation":[]},{"given":"Nicole","family":"D\u00e9glon","sequence":"additional","affiliation":[]},{"given":"Patrick","family":"Aebischer","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0168-3659(02)00353-X_BIB1","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1146\/annurev.pharmtox.37.1.239","article-title":"Pharmacology of neurotrophic factors","volume":"37","author":"Hefti","year":"1997","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/S0168-3659(02)00353-X_BIB2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-0173(98)00004-6","article-title":"The role of neuronal growth factors in neurodegenerative disorders of the human brain","volume":"27","author":"Connor","year":"1998","journal-title":"Brain Res. Rev."},{"key":"10.1016\/S0168-3659(02)00353-X_BIB3","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1023\/A:1011911912174","article-title":"Localized delivery of proteins in the brain: can transport be customized?","volume":"15","author":"Haller","year":"1998","journal-title":"Pharm. Res."},{"key":"10.1016\/S0168-3659(02)00353-X_BIB4","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0166-2236(00)01899-3","article-title":"Recombinant proteins for neurodegenerative diseases: the delivery issue","volume":"24","author":"Aebischer","year":"2001","journal-title":"Trends Neurosci."},{"key":"10.1016\/S0168-3659(02)00353-X_BIB5","doi-asserted-by":"crossref","first-page":"4146","DOI":"10.1523\/JNEUROSCI.13-10-04146.1993","article-title":"Brain-derived neurotrophic factor (BDNF) prevents the degeneration of medial septal cholinergic neurons following fimbria transection","volume":"13","author":"Morse","year":"1993","journal-title":"J. Neurosci."},{"key":"10.1016\/S0168-3659(02)00353-X_BIB6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1006\/exnr.1994.1076","article-title":"Distribution of intracerebral ventricularly administered neurotrophins in rat brain and its correlation with trk receptor expression","volume":"127","author":"Yan","year":"1994","journal-title":"Exp. Neurol."},{"key":"10.1016\/S0168-3659(02)00353-X_BIB7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF02257624","article-title":"Nerve growth factor affects 11C-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer patient (case report)","volume":"4","author":"Olson","year":"1992","journal-title":"J. Neural Transm. Park. Dis. Dement. Sect."},{"key":"10.1016\/S0168-3659(02)00353-X_BIB8","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000017069","article-title":"Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer\u2019s disease","volume":"9","author":"Eriksdotter Jonhagen","year":"1998","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/S0168-3659(02)00353-X_BIB9","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/1531-8249(199909)46:3<419::AID-ANA21>3.0.CO;2-Q","article-title":"Clinicopathological findings following intraventricular glial-derived neurotrophic factor treatment in a patient with Parkinson\u2019s disease","volume":"46","author":"Kordower","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/S0168-3659(02)00353-X_BIB10","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/cne.903570209","article-title":"Differential distribution of exogenous BDNF, NGF, and NT-3 in the brain corresponds to the relative abundance and distribution of high-affinity and low-affinity neurotrophin receptors","volume":"357","author":"Anderson","year":"1995","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/S0168-3659(02)00353-X_BIB11","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1089\/hum.1997.8.16-1881","article-title":"A gene therapy approach to regulated delivery of erythropoietin as a function of oxygen tension","volume":"8","author":"Rinsch","year":"1997","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/S0168-3659(02)00353-X_BIB12","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1089\/hum.1996.7.17-2135","article-title":"Central nervous system delivery of recombinant ciliary neurotrophic factor by polymer encapsulated differentiated C2C12 myoblasts","volume":"7","author":"D\u00e9glon","year":"1996","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/S0168-3659(02)00353-X_BIB13","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2337\/diabetes.45.2.257","article-title":"Expression and functional activity of glucagon, glucagon-like peptide I, and glucose-dependent insulinotropic peptide receptors in rat pancreatic islet cells","volume":"45","author":"Moens","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/S0168-3659(02)00353-X_BIB14","doi-asserted-by":"crossref","first-page":"5587","DOI":"10.1523\/JNEUROSCI.20-15-05587.2000","article-title":"Complete and long-term rescue of lesioned adult motoneurons by lentiviral-mediated expression of glial cell line-derived neurotrophic factor in the facial nucleus","volume":"20","author":"Hottinger","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/S0168-3659(02)00353-X_BIB15","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1126\/science.290.5492.767","article-title":"Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson\u2019s disease","volume":"290","author":"Kordower","year":"2000","journal-title":"Science"},{"key":"10.1016\/S0168-3659(02)00353-X_BIB16","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1998"},{"key":"10.1016\/S0168-3659(02)00353-X_BIB17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0014-4886(90)90049-X","article-title":"NGF released from a polymer matrix prevents loss of ChAT expression in basal forebrain neurons following a fimbria\u2013fornix lesion","volume":"110","author":"Hoffman","year":"1990","journal-title":"Exp. Neurol."},{"key":"10.1016\/S0168-3659(02)00353-X_BIB18","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1006\/exnr.2000.7411","article-title":"Implantation of bioactive growth factor-secreting rods enhances fetal dopaminergic graft survival, outgrowth density, and functional recovery in a rat model of Parkinson\u2019s disease","volume":"164","author":"Tornqvist","year":"2000","journal-title":"Exp. Neurol."},{"key":"10.1016\/S0168-3659(02)00353-X_BIB19","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1523\/JNEUROSCI.17-01-00325.1997","article-title":"GDNF reduces drug-induced rotational behavior after medial forebrain bundle transection by a mechanism not involving striatal dopamine","volume":"17","author":"Tseng","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/S0168-3659(02)00353-X_BIB20","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1006\/exnr.1997.6718","article-title":"Implants of polymer-encapsulated genetically modified cells releasing glial cell line-derived neurotrophic factor improve survival, growth, and function of fetal dopaminergic grafts","volume":"149","author":"Sautter","year":"1998","journal-title":"Exp. Neurol."},{"key":"10.1016\/S0168-3659(02)00353-X_BIB21","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1097\/00001756-199806010-00027","article-title":"Neurturin protects dopaminergic neurons following medial forebrain bundle axotomy","volume":"9","author":"Tseng","year":"1998","journal-title":"NeuroReport"},{"key":"10.1016\/S0168-3659(02)00353-X_BIB22","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0963-6897(97)00163-2","article-title":"Cellular delivery of CNTF but not NT-4\/5 prevents degeneration of striatal neurons in a rodent model of Huntington\u2019s disease","volume":"7","author":"Emerich","year":"1998","journal-title":"Cell Transplant."},{"key":"10.1016\/S0168-3659(02)00353-X_BIB23","doi-asserted-by":"crossref","first-page":"5168","DOI":"10.1523\/JNEUROSCI.16-16-05168.1996","article-title":"Implants of encapsulated human CNTF-producing fibroblasts prevent behavioral deficits and striatal degeneration in a rodent model of Huntington\u2019s disease","volume":"16","author":"Emerich","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/S0168-3659(02)00353-X_BIB24","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/386395a0","article-title":"Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington\u2019s disease","volume":"386","author":"Emerich","year":"1997","journal-title":"Nature"},{"key":"10.1016\/S0168-3659(02)00353-X_BIB25","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1089\/10430340050015220","article-title":"Restoration of cognitive and motor functions by ciliary neurotrophic factor in a primate model of Huntington\u2019s disease","volume":"11","author":"Mittoux","year":"2000","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/S0168-3659(02)00353-X_BIB26","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/nm0696-696","article-title":"Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients","volume":"2","author":"Aebischer","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/S0168-3659(02)00353-X_BIB27","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1177\/096368970000900404","article-title":"Evaluation of an intrathecal immune response in amyotrophic lateral sclerosis patients implanted with encapsulated genetically engineered xenogeneic cells","volume":"9","author":"Zurn","year":"2000","journal-title":"Cell Transplant."},{"key":"10.1016\/S0168-3659(02)00353-X_BIB28","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0958-1669(98)80029-3","article-title":"Lentiviruses as gene transfer agents for delivery to non-dividing cells","volume":"9","author":"Naldini","year":"1998","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/S0168-3659(02)00353-X_BIB29","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/1521-2254(200009\/10)2:5<308::AID-JGM131>3.0.CO;2-3","article-title":"Lentiviral vectors: excellent tools for experimental gene transfer and promising candidates for gene therapy","volume":"2","author":"Vigna","year":"2000","journal-title":"J. Gene Med."},{"key":"10.1016\/S0168-3659(02)00353-X_BIB30","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1089\/10430340050016256","article-title":"Self-inactivating lentiviral vectors with enhanced transgene expression as potential gene transfer system in Parkinson\u2019s disease","volume":"11","author":"D\u00e9glon","year":"2000","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/S0168-3659(02)00353-X_BIB31","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1006\/exnr.2000.7409","article-title":"Lentiviral vectors as a gene delivery system in the mouse midbrain: cellular and behavioural improvements in a 6-OHDA model of Parkinson\u2019s disease using GDNF","volume":"164","author":"Bensadoun","year":"2000","journal-title":"Exp. Neurol."},{"key":"10.1016\/S0168-3659(02)00353-X_BIB32","doi-asserted-by":"crossref","first-page":"10589","DOI":"10.1128\/JVI.74.22.10589-10599.2000","article-title":"Development of multigene and regulated lentivirus vectors","volume":"74","author":"Reiser","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/S0168-3659(02)00353-X_BIB33","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1006\/mthe.2000.0083","article-title":"Lentiviral vectors: regulated gene expression","volume":"1","author":"Kafri","year":"2000","journal-title":"Mol. Ther."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836590200353X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836590200353X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T11:28:37Z","timestamp":1583926117000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016836590200353X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,2]]},"references-count":33,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2003,2]]}},"alternative-id":["S016836590200353X"],"URL":"https:\/\/doi.org\/10.1016\/s0168-3659(02)00353-x","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2003,2]]}}}